Research highlights in breast cancer

Pembrolizumab combined with xelox and bevacizumab shows higher efficacy than standard therapeutic regimen in mCRC

Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2-negative advanced GEJ cancer

Abemaciclib and fulvestrant show improved efficacy in HR+, HER2- advanced breast cancer compared to placebo and fulvestrant

Combination of zanubrutinib and venetoclax shows promise in high-risk TN CLL/SLL with del(17p) and/or TP53 mutation

Patient expectations and shared decision making in aRCC

Encouraging results using mismatched unrelated donors in stem cell transplantation

ASCO 2024: Highlights and analysis

ASCO 2024: Two studies report on isatuximab combos in transplant-ineligible patients with newly diagnosed multiple myeloma

Looking at real world evidence on PSA testing in prostate cancer

Telehealth delivery of palliative care an effective alternative to in-person visits for patients with advanced lung cancer

Safety and quality of life assessment, how do they impact patient decision? KCCure survey – part B